A new CSP position was established today on Abbott Laboratories (ABT). All prices include IB commissions.
This is the third position on ABT.
| Criteria | Value |
|---|---|
| Dividend Champions Status | Champion |
| Years of Consecutive Dividend Increases | 39 |
| Years of Positive Free Cash Flow (last 10 years) | 10 |
| Fair Value Estimate | $70.00 |
| Target Buy Price | $56.00 |
| Target Margin of Safety | 20.00% |
| Actual Buy Price | $55.00 |
| Actual Margin of Safety | 21.43% |
| Date | Stock | Description | Transaction | Status | Stock Investment | Income Generated |
|---|---|---|---|---|---|---|
| 2/22/2012 | ABT | CSP Margin Used | CSP 100 ABT @ 55.00 | ($5,500.00) | ||
| 2/22/2012 | ABT | Initial Put Option | STO 1 Apr12 55.00 Put @ 0.92 | $92.12 |
Position Summary
| Cost Basis | ($5,500.00) |
| Income Generated | $92.12 |
| Percent Income Generated | 1.67% |
| Annualized Income Generated | 10.54% |
| Net Profit If Assigned | $92.12 |
| Percent Return If Assigned | 1.67% |
| Annualized Return If Assigned | 10.54% |
| Days Held to Expiration | 58 days |
